Business
Bionik Laboratories Appoints Dr. Audrey D. Thévenon and Charles Matine to its Board of Directors
Bionik Laboratories Appoints Dr. Audrey D. Thévenon and Charles Matine to its Board of Directors.
About this update from Bionik Laboratories Corp.
[{"type":"text","content":"\n\n\n\nBionik Laboratories Appoints Dr. Audrey D. Thévenon and Charles Matine to its Board of Directors\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nBionik Laboratories Appoints Dr. Audrey D. Thévenon and Charles Matine to its Board of Directors\nGains substantial scientific, marketing and branding expertise\nPR Newswire\nTORONTO and BOSTON, Sept. 13, 2018\n\n\n\nTORONTO and BOSTON, Sept. 13, 2018 /PRNewswire/ -- Bionik Laboratories Corp. (OTCQB: BNKL) (\"Bionik\" or the \"Company\"), a pioneering healthcare company combining artificial intelligence and innovative robotics technology to help individuals from hospital to home to regain mobility, announced today the appointments of Audrey D. Thévenon, Ph.D. and Charles Matine to its Board of Directors. These appointments coincide with the resignation of directors Michal Prywata, effective September 7, 2018, and Marc Mathieu, effective August 1, 2018, and fill the two vacancies on the Board. Prywata will continue to contribute to the Board as an observer. With these changes Bionik has seven directors including four independent directors.\n\n \n \n\n \nDr. Thévenon is a Program Officer on the Board of Life Sciences at The National Academies of Sciences, Engineering and Medicine, where she also serves as the Managing Editor of the journal Institute for Laboratory Animal Research. Since joining the Academies, Dr. Thévenon has supported collaborative regional and international activities aimed at promoting transdisciplinary research. Prior to the Academies, Dr. Thévenon completed a Postdoctoral Fellowship at the University of Hawaii in placental pharmacology, followed by another fellowship at Uniformed Services University of the Health Sciences in Bethesda, Md. working on two PEPFAR-funded HIV-Malaria projects in collaboration with Nigeria and Kenya.\nDr. Thévenon has a Ph.D. and an MS, both in Biology, from Georgetown University, as well as an MS in Cell Biology & Physiology and a BS in Life Sciences and Environment from the University of Rennes 1 in France. Bionik believes that Dr. T...